177Lu-DOTATATE (Lutathera) Therapy in 68Ga-DOTATATE PET/CT-Negative Liver Metastases of a Neuroendocrine Tumor

被引：2
|
作者：
Ventura, David [1 ]
Roll, Wolfgang [1 ]
Kasper, Hans-Udo [2 ]
Rahbar, Kambiz [1 ]
Stegger, Lars [1 ]
机构：
[1] Univ Hosp Muenster, Dept Nucl Med, Albert Schweitzer Campus 1,Gebaude A1, D-48149 Munster, Germany
[2] Clemenshosp Muenster, Inst Pathol, Munster, Germany
来源：
CLINICAL NUCLEAR MEDICINE | 2023年 / 48卷 / 12期
关键词：
PRRT; GEP-NET; PET/CT; DOTATATE; SSTR; ANALOG;
D O I：
10.1097/RLU.0000000000004888
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 73-year-old man with metastatic pancreatic neuroendocrine tumor was evaluated with Ga-68-DOTATATE PET/CT for peptide receptor radionuclide therapy. Both PET-positive and negative lesions were seen in the liver, along with extrahepatic metastases. Histopathology was obtained from one of the PET-negative liver lesions to exclude secondary malignancy. Histology confirmed a well-differentiated (G2) metastasis of pNET with high somatostatin receptor expression. We initiated peptide receptor radionuclide therapy with close monitoring of the PET-negative liver metastases. We present a rare case, where posttherapeutic scintigraphy revealed vigorous uptake of Lu-177-DOTATATE even in the Ga-68-DOTATATE PET-negative liver metastases. Follow-up PET/CT showed a partial response to therapy.
引用
收藏
页码：E585 / E587
页数：3
相关论文
共 50 条
  • [41] Estimation of tumor burden from 68Ga- Dotatate-PET/CT and day-7 planar 177Lu images, for patients treated with 177Lu-Dotatate
    Gleisner, K. Sjogreen
    Gustafsson, J.
    Stenvall, A.
    Roth, D.
    Hindorf, C.
    Jonsson, L.
    Larsson, E.
    Olsson, T.
    Sundlov, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S376 - S377
  • [42] Receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumours
    Bodei, L.
    Cremonesi, M.
    Grana, C.
    Bartolomei, M.
    Baio, S.
    Bufi, G.
    Fiorenza, M.
    Obenaus, E.
    Paganelli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S214 - S214
  • [43] Re: Hepatocellular Carcinoma Mimicking Neuroendocrine Tumor Metastasis on 68Ga-DOTATATE PET/CT
    Filippi, Luca
    Bagni, Oreste
    Schillaci, Orazio
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (03) : 258 - 259
  • [44] Variability of 68Ga-DOTATATE Uptake on PET/CT Among Different Neuroendocrine Tumor Grades
    Waits, Timothy
    Jayavarapu, Ravi
    Chauhan, Arran
    Oates, M.
    Anthony, Lowell
    El Khouli, Riham
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [45] Preoperative prediction of pancreatic neuroendocrine tumor grade based on 68Ga-DOTATATE PET/CT
    Jiao Ma
    Xiaoyong Wang
    Mingsong Tang
    Chunyin Zhang
    Endocrine, 2024, 83 : 502 - 510
  • [46] 68Ga-DOTATATE PET/CT Imaging in Carotid Body Tumor
    Gayana, Shankaramurthy
    Mittal, Bhagwant Rai
    Bhattacharya, Anish
    Radotra, Bishan Dass
    Gupta, Ashok K.
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (04) : E191 - E193
  • [47] 68Ga-DOTATATE PET/CT in Focal Fatty Sparing of the Liver
    Hod, Nir
    Levin, Daniel
    Anconina, Reut
    Taragin, Benjamin H.
    Dudnik, Julia
    Lantsberg, Sophie
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (10) : 815 - 817
  • [48] Early Response to Everolimus Therapy Detected on 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor
    Ozkan, Elgin
    Soydal, Cigdem
    Semirgin, Sibel Ucak
    Yapici, Oktay
    Atmaca, Aysegul
    Demirag, Guzin
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (07) : 561 - 563
  • [49] Preoperative prediction of pancreatic neuroendocrine tumor grade based on 68Ga-DOTATATE PET/CT
    Ma, Jiao
    Wang, Xiaoyong
    Tang, Mingsong
    Zhang, Chunyin
    ENDOCRINE, 2024, 83 (02) : 502 - 510
  • [50] Confirmation of Intracranial Neuroendocrine Metastasis Using 68Ga-DOTATATE PET/CT
    Ismail, Rahim
    Manganaro, Mark
    Bai, James
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2023, 51 (01) : 70 - 72
12345